| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1008990092 |
| P356 | DOI | 10.1038/GT.2014.28 |
| P8608 | Fatcat ID | release_ygocpa7zu5g7xdtvzlkwk2g5ue |
| P698 | PubMed publication ID | 24670994 |
| P5875 | ResearchGate publication ID | 261138415 |
| P50 | author | B T Harmon | Q87525155 |
| P2093 | author name string | L Padegimas | |
| M J Cooper | |||
| O Sesenoglu-Laird | |||
| B L Waszczak | |||
| A E Aly | |||
| P2860 | cites work | Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations | Q45295266 |
| A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain | Q45361570 | ||
| A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer's disease | Q45703990 | ||
| Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy | Q45863679 | ||
| Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo | Q45870757 | ||
| Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung | Q47331709 | ||
| miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model | Q48397272 | ||
| Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway | Q48630546 | ||
| Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage | Q48821396 | ||
| Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration | Q80356946 | ||
| Fluid mechanics in the perivascular space | Q83222338 | ||
| Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery | Q27325842 | ||
| Efficient non-viral ocular gene transfer with compacted DNA nanoparticles | Q33267297 | ||
| Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina | Q33510137 | ||
| Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa | Q33752902 | ||
| Pericytes: pluripotent cells of the blood brain barrier | Q34013140 | ||
| Intranasal delivery of cells to the brain. | Q34016739 | ||
| Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations | Q34458377 | ||
| Progress and problems with the use of viral vectors for gene therapy | Q35120176 | ||
| DNA nanoparticles: detection of long-term transgene activity in brain using bioluminescence imaging | Q35214209 | ||
| Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors | Q35226125 | ||
| Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain. | Q35876200 | ||
| Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor | Q36128982 | ||
| DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice. | Q36190772 | ||
| Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system | Q36464407 | ||
| Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector | Q36485052 | ||
| Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma | Q36861449 | ||
| The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain | Q37313963 | ||
| Intranasal delivery to the central nervous system: mechanisms and experimental considerations | Q37624592 | ||
| Viral vectors for gene delivery to the central nervous system | Q37946113 | ||
| Nanotechnological advances for the delivery of CNS therapeutics | Q37958426 | ||
| Intranasal delivery of biologics to the central nervous system | Q37961386 | ||
| Polymeric nanoparticles for drug delivery to the central nervous system | Q37972516 | ||
| Neurovascular unit: a focus on pericytes | Q37988811 | ||
| Brain pericyte plasticity as a potential drug target in CNS repair | Q38069738 | ||
| Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier | Q39457264 | ||
| Long-term transgene expression in the central nervous system using DNA nanoparticles | Q39505583 | ||
| Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors | Q39674615 | ||
| Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles | Q40307368 | ||
| Optimization of hCFTR lung expression in mice using DNA nanoparticles | Q40309913 | ||
| Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice | Q42382222 | ||
| Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution | Q42473767 | ||
| Delivery of interferon-beta to the monkey nervous system following intranasal administration | Q42525162 | ||
| Improperly folded green fluorescent protein is secreted via a non-classical pathway | Q42810370 | ||
| Nanoparticles of compacted DNA transfect postmitotic cells | Q44478822 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 514-521 | |
| P577 | publication date | 2014-03-27 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain | |
| P478 | volume | 21 |
| Q38685603 | Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors |
| Q55282219 | Chitosan-Mangafodipir nanoparticles designed for intranasal delivery of siRNA and DNA to brain. |
| Q36888146 | Designing DNA nanodevices for compatibility with the immune system of higher organisms |
| Q35529165 | Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans |
| Q92095826 | Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson's disease mouse model |
| Q40219437 | Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I. |
| Q64869973 | Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson's Disease |
| Q38569775 | Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier |
| Q89587105 | Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures |
| Q38887870 | Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics |
| Q38536735 | Recent prospective of surface engineered Nanoparticles in the management of Neurodegenerative disorders |
Search more.